Dice CEO: Energy, T...
BioMarin Pharmaceuticals Inc (BMRN: NASDAQ)
$35.53 -0.11 | -0.31%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -53.84M | 205.82M | -488.00K | 30.83M |
| Operating Gains/Losses | 4.32M | 15.82M | 3.59M | 6.65M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -18.46M | -13.04M | -19.24M | -37.32M |
| (Increase) Decrease in Inventories | -20.42M | -31.04M | -5.50M | -13.94M |
| (Increase) Decrease In Other Current Assets | 2.54M | 3.24M | 37.42M | -43.06M |
| (Decrease) Increase In Payables | 10.11M | 2.04M | 8.02M | 7.43M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 127.00K | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 1.12M | -3.43M | -820.00K | -2.10M |
| Other Non-Cash Items | 48.87M | 37.59M | 43.78M | 31.19M |
| Net Cash From Continuing Operations | 18.75M | 18.75M | 87.73M | -9.18M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 18.75M | 18.75M | 87.73M | -9.18M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 761.18M |
| Purchases of Property, Plant & Equipment | -154.22M | -49.46M | -89.80M | -56.37M |
| Acquisitions | 0.00 | -32.95M | -8.37M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -733.13M |
| Other Cash from Investing Activities | 0.00 | 0.00 | -17.52M | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -89.56M | -101.34M | -79.68M | -19.08M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 33.59M | 33.10M | 11.00M | 28.44M |
| Repayment of Long-Term Debt | -5.01M | -14.28M | -73.78M | -6.59M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 415.00K | -15.32M | -1.00M | 960.00K |
| Net Cash From Financing Activities | 29.00M | 3.50M | -63.79M | 22.81M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -41.81M | -79.09M | -55.73M | -5.44M |
Portfolios with BMRN
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- UserScottrade IRA
- UserEverett Bishop Portfolio 1
- ContributorEarnings Short Squeeze Play...
- Userwjwallace Portfolio
- ContributorStocks At New 52-Week Highs...
- ProColumbia Wanger Asset Manag...
- Contributor21 Stocks to Watch
- ContributorBreakout Stocks Of The Week...
Latest BMRN Headlines from TheStreet
- BioMarin Stock Falls On Unusually High Volume (BMRN) 05.31.12 | 02:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.29.12 | 10:05 am
- 8 Stocks Rising on Big Volume 05.21.12 | 01:05 pm
- 5 Stocks Hit 52-Week Highs 05.16.12 | 01:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.16.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.27.12 | 03:04 am
- BioMarin Pharmaceutical's CEO Discusses Q4 2011 Earning Results - Earnings Call Transcript 02.16.12 | 11:02 pm
- 5 Earnings Stocks Poised to Pop 02.16.12 | 12:02 pm
- BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
Press Releases for BMRN
- IU Confidential Publishes Biotech Investment Report - PR Newswire 07.28.11 | 09:07 am
- BioMarin Launches Firdapse In The European Union - PR Newswire 04.19.10 | 09:04 am
- BioMarin To Present At The Barclays Capital Global Healthcare Conference - PR Newswire 03.17.10 | 09:03 am
- BioMarin To Acquire LEAD Therapeutics - PR Newswire 02.04.10 | 04:02 pm
Partner Headlines for BMRN
- BioMarin Prices Share Offering - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Analyst Insights: Finish Line, BioMarin Pharma, Laboratory Corp, Ocz Technology, AstraZeneca May 31st - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Loss at BioMarin Wider Than Expected - Analyst Blog - Zacks 02.17.12 | 09:02 am
- Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone and United Parcel Services - Press Releases - Zacks 02.14.12 | 09:02 am
- BioMarin Pharmaceutical (BMRN) - Bear of the Day - Zacks 02.14.12 | 01:02 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 02.08.12 | 09:02 am
- BioMarin's Facility Expansion Backed - Analyst Blog - Zacks 12.22.11 | 10:12 am
- Facility Expansion at BioMarin - Analyst Blog - Zacks 11.29.11 | 10:11 am
- Activist Hedge Fund Accipiter Capital's Top Stock Picks - Seeking Alpha 11.29.11 | 09:11 am





